Related news for: CEO
Mater Research CEO Professor Maher Gandhi has been appointed to a new National Blood Cancer Taskforce to deliver Australia’s first National Strategic Action Plan for Blood Cancer.
Mater Research CEO Professor Maher Gandhi has secured additional funding from the Leukaemia Foundation to investigate a new therapeutic approach for follicular lymphoma (FL).
Professor Maher Gandhi will be appointed as Chief Executive Officer of Mater Research and Director of MRI-UQ, effective May 1 2019.
Dr Peter Steer has commenced his appointment as Mater Group Chief Executive Officer.